Black Men Report More Regret Over Prostate Cancer Treatment Decisions
Mistrust and concerns about masculinity are important factors that influence Black men’s experience during prostate cancer management.
Prostate Cancer
Use of Commercial Genomic Testing for Prostate Cancer ‘Highly Variable’ in the United States
Investigators evaluated a large sample of commercially insured patients with prostate cancer to assess use of tissue-based gene expression testing.
Mediterranean Diet May Lower Prostate Cancer Progression Risk
In a study of men on active surveillance for localized prostate cancer, each 1-unit increase in Mediterranean diet score, calculated based on patients’ baseline food frequency questionnaire information, was associated with a 12% decreased risk for Gleason grade group progression.
Orgovyx Now Available for Advanced Prostate Cancer
Orgovyx is an oral nonpeptide gonadotropin-releasing hormone (GnRH) receptor antagonist.
Salvage Therapies for Radiorecurrent Prostate Cancer Offer Similar RFS
Investigators found no significant differences in 5-year RFS rates between RP and the other salvage modalities.
Statins May Benefit Patients Receiving ADT for Relapsed Prostate Cancer
In a study, statin use was associated with a 36% decreased risk for death among men initiating androgen deprivation therapy for recurrent prostate cancer following primary or salvage radiation therapy.
Study: No Need to Rush Surgery for High-Risk Prostate Cancer
Delaying radical prostatectomy for high-risk clinically localized prostate cancer for up to 6 months does not increase the risk for adverse pathologic outcomes, a study found.
FDA Approves First Oral Hormone Therapy for Advanced Prostate Cancer
Phase 3 trial data show 96.7 percent of patients who received Orgovyx achieved and maintained castrate levels of testosterone.
Optimal Sequencing of Therapy Identified for Prostate Cancer
Patients with prostate cancer who received androgen deprivation therapy in the adjuvant setting instead of the neoadjuvant setting had better clinical outcomes.
Prostate Cancer Pathology Not Worse With Delayed Surgery
Delayed radical prostatectomy not linked to higher risk for adverse pathological outcomes in high-risk prostate cancer.
-
Loading...
-
Loading...
Next post in Prostate Cancer
